ArticleCureus2025
The Pathological Effects of Cardiac Transplantation in a 27-Year-Old Patient Leading to Cardiac Allograft Rejection and End-Stage Renal Disease: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart transplantation remains the gold standard for patients with end-stage heart failure, offering a median survival of 12 years. However, long-term complications, such as cardiac allograft vasculopathy (CAV), infections, malignancies, and renal dysfunction, pose significant challenges. We present the case of a 27-year-old male who underwent heart transplantation at age 15 for dilated cardiomyopathy and now presents with multisystem failure. The patient arrived at the emergency department with dyspnea, abdominal distention, and respiratory distress. He experienced pulseless electrical activity and was successfully resuscitated and transferred to the ICU. Echocardiography revealed a reduced ejection fraction (30%-35%), consistent with graft dysfunction. Laboratory results showed severe anemia, elevated blood urea nitrogen (BUN) and creatinine levels, and an estimated glomerular filtration rate (eGFR) of 9 mL/min/1.73 m², consistent with end-stage renal disease (ESRD). He was on hemodialysis and long-term immunosuppressive therapy, including tacrolimus and mycophenolate. Despite stabilization, his prognosis remained poor, prompting evaluation for combined heart and kidney transplantation. This case highlights the long-term risks of heart transplantation, particularly the development of CAV and ESRD. CAV affects over half of recipients within 10 years and can lead to graft failure, while immunosuppressants contribute significantly to renal decline. Recent data suggest that dual-organ transplantation in patients with severe renal dysfunction improves survival outcomes, particularly among younger candidates. However, such decisions involve ethical considerations around organ allocation and long-term outcomes. Our patient, due to his age and clinical deterioration, was a strong candidate for dual transplantation. This case underscores the importance of early recognition of post-transplant complications and supports the need for individualized, multidisciplinary approaches. As dual transplants become more common, careful patient selection and continued research are essential to maximize outcomes and ensure ethical distribution of scarce resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.